CHC – The Cancer & Hematology Centers


Name of this trial: SAPHAIRE What type of cancer is this for? Warm Autoimmune Hemolytic Anemia (wAIHA) Who is this trial for? Patients with warm autoimmune hemolytic anemia who have failed at 1 least 1 prior line of treatment. Failure, meaning a drop in hemoglobin of ≥ 1g/dL and an increase in LDH levels.  Patients